ArticleIndian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion2025
Mutation Analysis for Hemoglobinopathies in Eastern Jharkhand.
Article in Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thalassemia is the commonest monogenic disorder worldwide and India is home to significant proportion of these patients. The prevalence of beta-thalassemia trait varies around the country ranging from 0.35 to 37.5%. Data regarding mutation spectrum of beta thalassemia from Jharkhand are scanty, though this state has high prevalence of thalassemia. The Aim of study was to explore different mutations prevalent in transfusion-dependent-thalassemia patients in age group of 6 months to 18 years, coming to our centre over period of one month for regular transfusion. Basic characteristics were noted and blood sample were sent for genetic analysis. We studied 51 patients. Their mean age was 9 years. Severe β+/ severe β + was most common genotype found in 78.4% patients followed by severe β+/β0. We found that c.92 + 5 C > G was the commonest mutation. We also report one patient with extremely rare mutation called as Hb Monroe (c.92G > C). The mutation c.92 + 5 C > G has been reported as the commonest mutation in various regions of our country but its frequency varies from 55 to about 71.4%. We found even greater frequency of this mutation (88.2%) in our sample. This study serves to fill the gap in knowledge of mutation spectrum in this under-represented area of our country.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.